12 results · 28ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

GYRUS ENT NERVE STIMULATOR

FDA 510(k)
FDA Class 2 ·Ear, Nose, Throat

XENOSTRIP-TV TRICHOMONAS CASSETTE TEST, MODEL C1383.01

FDA 510(k)
FDA Class 1 ·Microbiology

ACON MTD ONE STEP METHADONE TEST STRIP AND TEST DEVICE

FDA 510(k)
FDA Class 2 ·Clinical Toxicology

CYSTOTOME CYSTOENTEROSTOMY NEEDLE KNIFE

FDA Adverse Event
Malfunction ·COOK IRELAND LTD·Product code KNS·March 15, 2019

MUSTANG¿

FDA Adverse Event
Malfunction ·BOSTON SCIENTIFIC - GALWAY·Product code LIT·March 26, 2013

PARADIGM REAL-TIME INSULIN INFUSION PUMP

FDA Adverse Event
Injury ·MEDTRONIC PUERTO RICO OPERATIONS MED-REL·Product code MDS·March 8, 2011

RESTERILIZED SURGASSIST LINEAR CUTTER

FDA Adverse Event
Malfunction ·ASCENT HEALTHCARE SOLUTIONS·Product code GCJ·March 25, 2008

CYSTOTOME CYSTOENTEROSTOMY NEEDLE KNIFE

FDA Adverse Event
Malfunction ·COOK IRELAND LTD·Product code KNS·February 4, 2019

CYSTOTOME CYSTOENTEROSTOMY NEEDLE KNIFE

FDA Adverse Event
Malfunction ·COOK IRELAND LTD·Product code KNS·August 8, 2018

CYSTOTOME CYSTOENTEROSTOMY NEEDLE KNIFE

FDA Adverse Event
Malfunction ·COOK IRELAND LTD·Product code KNS·August 8, 2019

Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

The Propaq LT Series monitors. Model numbers 802LTAN, 802LT0N, and 802LTRN. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medical-surgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. intended to be used by clinicians and medically qualified personnel for single or multiparameter vital signs monitoring of ambulatory and nonambulatory patients, including neonate, pediatric and adult patients. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medicalsurgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. The monitors can be used as stand-alone devices or as devices networked to an Acuity Central Station through wireless communication over a Welch Allyn FlexNet network.

FDA Enforcement
Class II ·Terminated·Welch Allyn Protocol, Inc·January 15, 2014